Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2001
11/15/2001WO2001085716A1 2-piperidone compounds for the treatment of cancer
11/15/2001WO2001085715A2 Aza- and polyazanthranyl amides and their use as medicaments
11/15/2001WO2001085701A1 5-ht7 receptor antagonists
11/15/2001WO2001085700A2 Hiv replication inhibiting pyrimidines and triazines
11/15/2001WO2001085699A2 Prodrugs of hiv replication inhibiting pyrimidines
11/15/2001WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001WO2001085693A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001WO2001085690A1 4-alkyl and 4-cycloalkyl derivatives of dihydropyridine npy antagonists
11/15/2001WO2001085675A2 Fluorous tagging compounds and their use
11/15/2001WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001WO2001085173A1 Alkylamine derivatives of dihydropyridine npy antagonists
11/15/2001WO2001085095A2 Chiral fluoroquinolizinone arginine salt forms
11/15/2001WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001WO2001017963A3 Aminoalkoxy carbazoles and their use as 5-ht ligands
11/15/2001WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/15/2001WO2000071507A3 INHIBITORS OF FACTOR Xa
11/15/2001WO2000050872A9 A system for cell-based screening
11/15/2001US20010041799 Diephenyl carbocyclic thioamide derivatives
11/15/2001US20010041723 Using agonists and antagonists of the nicotinergic acetylcholine receptors of insects such as fleas, lice and flies, on humans and animals
11/15/2001US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001US20010041714 Serotonin-7 (5-HT7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/15/2001US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001US20010041707 Selective antagonists for human alpha 1a receptors; benign prostatic hyperplasia; (+)-1-3-((4-(3,4-difluorophenyl)-2,5-dioxo-1,2,5,7-tetrahydro-4H-furo(3,4 -d)pyrimidine-3-carbonyl)amino)-propyl-4-(2-pyridyl)-piperidine
11/15/2001CA2409729A1 5-ht7 receptor antagonists
11/15/2001CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001CA2408343A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001CA2408095A1 Fluorous tagging compounds and their use
11/15/2001CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/15/2001CA2405968A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001CA2403264A1 Chiral fluoroquinolizinone arginine salt forms
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP1153920A1 Quinoline derivatives and quinazoline derivatives
11/14/2001EP1153013A2 5-ht1f agonists
11/14/2001EP1021437B1 Arylsulfonylimidazolone derivatives as an antitumor agent
11/14/2001EP0885212B1 Quinoxalinediones
11/14/2001EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001CN1322202A Quinazoline derivatives
11/14/2001CN1322201A Improved omeprazole process and compositions thereof
11/14/2001CN1322198A HIV replication inhibiting pyrimidines
11/14/2001CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001CN1322195A Substituted pyrroldinone, thizolidinone or oxazolidinone as herbicides
11/14/2001CN1322194A Substituted phenyl derivatives, their preparation and use
11/14/2001CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/13/2001US6316625 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
11/13/2001US6316623 Useful for screening in biological assays in order to identify pharmaceutically useful compounds
11/13/2001US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001US6316479 Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
11/13/2001US6316474 Treatment of pain, schizophrenia, parkinson's disease, stroke and depression
11/13/2001US6316471 Treating inflammatory or autoimmune diseases
11/13/2001US6316470 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
11/13/2001US6316468 Phenylindole derivatives as 5-HT2A receptor antagonists
11/13/2001US6316466 Pyrazole derivatives P-38 MAP kinase inhibitors
11/13/2001US6316459 O-benzyloxime ethers and crop protection agents containing these compounds
11/13/2001US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001US6316453 Aqueous pharmaceutical composition
11/13/2001US6316450 Compounds
11/13/2001US6316445 Tachykinin receptor antagonists
11/13/2001US6316444 SRC kinase inhibitor compounds
11/13/2001US6316437 Spirohydantoin compounds and uses thereof
11/13/2001US6316388 Antigrowth agents for plants
11/13/2001US6316020 For therapy of gastric acid related diseases in mammals
11/08/2001WO2001083571A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001WO2001083478A2 Hydantoin-containing glucokinase activators
11/08/2001WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001WO2001083473A1 Process for producing optically active sulfoxide derivative
11/08/2001WO2001083472A1 Muscarinic agonists
11/08/2001WO2001083470A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
11/08/2001WO2001083465A2 Alkynyl phenyl heteroaromatic glucokinase activators
11/08/2001WO2001083460A1 Cyclic compounds
11/08/2001WO2001083455A1 Process for the preparation of sterically hindered aryloxyamines
11/08/2001WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001WO2001040180A3 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
11/08/2001WO2001030765A3 Method for producing therapeutic agents for ulcers
11/08/2001WO2001029012A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001WO2001029011A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001US20010039343 Pesticides, fungicides, herbicides, insecticides, microbiocdes, drugs
11/08/2001US20010039290 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells
11/08/2001US20010039287 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/08/2001US20010039286 Especially substance P
11/08/2001US20010039285 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/08/2001US20010039283 11-hydroxy benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as antitumor agents
11/08/2001US20010039282 Desloratadine as non-sedating antihistamine, decongestant
11/08/2001US20010039277 Neuropeptide Y antagonists such as 2-chloro-5-(4-(3,4-dich loro-phenyl)-1H-imidazol-2-yl)-pyridine
11/08/2001US20010039271 For treatment of male erectile dysfunction, female sexual dysfunction
11/08/2001CA2407692A1 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001CA2407594A1 Muscarinic agonists
11/08/2001CA2407535A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
11/08/2001CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001CA2407231A1 Cyclic compounds
11/08/2001CA2407195A1 Process for the preparation of sterically hindered aryloxyamines
11/07/2001EP1151998A1 Estrogen agonists/antagonists
11/07/2001EP1151993A1 Cyclic amine derivatives and uses thereof
11/07/2001EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001EP1150980A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
11/07/2001EP1150977A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
11/07/2001EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
1 ... 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 ... 1080